Vés al contingut

L’enemic comú del Parkinson, el càncer de pròstata i l’Alzheimer

L'IRB Barcelona als mitjans
18 ag. 16

Images

Participants

Contact

Imatge
Communication Officer
Tel.+34 93 40 37255

El Heraldo de Aragón i altres mitjans s’han fet ressò de la investigació liderada per Xavier Salvatella, líder del Laboratori de Biofísica Molecular de l’IRB Barcelona, i publicada a ACS Chemical Biology. L’estudi desvela, contràriament al que s’havia cregut fins ara, que regions desordenades de proteïnes podrien utilitzar-se com a diana terapèutica, amb possibles aplicacions en Alzheimer, Parkinson i càncer de pròstata.

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).